National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -10 of 36         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Closed


under 65





WCCC-CO-7711R
NCI-D80-048-183

Last Modified: 7/5/2006  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Completed


no age specified


NCI


NCI-81-C-72
NCI-MB-153, NCI-T83-1460N, T83-1460


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Closed


no age specified


NCI


NCCTG-813251
MAYO-813251, NCCTG-81-32-51

Last Modified: 11/1/1988  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Closed


18 to 69





WCCC-CO-8111
NCI-D81-048-515

Last Modified: 4/26/2007  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


20 to 70





MSHMC-REN-2



6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Completed


no age specified





PVSG-2



7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


no age specified





CBCG-4280
UICC-72059


8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Closed


postmenopausal





CBCG-4400


Last Modified: 8/10/2007  

9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Completed


75 and under


NCI


CLB-8082
CALGB-8082

Last Modified: 8/10/2007  

10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


16 to 70


NCI


CLB-8281
CALGB-8281

   
    1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov